A 1 Drug Discovery Technologies Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 04-07-2024
- Paid Up Capital ₹ 0.10 M
as on 04-07-2024
- Company Age 15 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 6.67%
(FY 2022)
- Profit 6.67%
(FY 2022)
- Ebitda
- Net Worth 25.48%
(FY 2022)
- Total Assets -0.90%
(FY 2022)
About A 1 Drug Discovery Technologies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gokaraju Devi and Gokaraju Raju serve as directors at the Company.
- CIN/LLPIN
U73100AP2009PTC064734
- Company No.
064734
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
13 Aug 2009
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Vijayawada, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at A 1 Drug Discovery Technologies?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gokaraju Devi  | Director | 27-Mar-2015 | Current |
| Gokaraju Raju | Director | 13-Aug-2009 | Current |
Financial Performance of A 1 Drug Discovery Technologies.
A 1 Drug Discovery Technologies Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 6.67% increase. The company also saw a slight improvement in profitability, with a 6.67% increase in profit. The company's net worth Soared by an impressive increase of 25.48%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of A 1 Drug Discovery Technologies?
In 2022, A 1 Drug Discovery Technologies had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Rama Raju Fish Farms Pvt LtdActive 31 years 10 monthsGokaraju Devi and Gokaraju Raju are mutual person
- Laila Foods And Feeds Private LimitedActive 31 years 5 days
Gokaraju Devi and Gokaraju Raju are mutual person
- Sreya Fish Farms Private LimitedActive 5 years 4 months
Gokaraju Devi and Gokaraju Raju are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at A 1 Drug Discovery Technologies?
Unlock and access historical data on people associated with A 1 Drug Discovery Technologies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of A 1 Drug Discovery Technologies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped A 1 Drug Discovery Technologies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
